Progesterone/estradiol
General Drug Information and Indications
Combination reproductive hormone therapy for estrus synchronization and uterine priming in mares; progesterone maintains uterine quiescence and estradiol induces receptivity and LH release.
Combination sex hormone therapy: progesterone (P4) — progesterone receptor agonist → uterine quiescence, endometrial secretory transformation; estradiol (E2) — estrogen receptor agonist → stimulates LH surge and uterine receptivity. Combined for estrus synchronization, uterine priming, and embryo transfer preparation in mares.
Key information
HUMAN SAFETY: Wear gloves — dermal absorption. Refrigerate injectable solutions. Used for luteal supplementation and maintenance of early pregnancy in mares. Monitor progesterone levels to confirm therapeutic range.
How to Give this Medication
Injectable (oil-based): warm vial to room temperature; administer IM into large muscle mass. Oral (compounded): Administer orally. May be given with food to improve compliance and reduce GI upset. Administer with food to reduce GI adverse effects. Topical (compounded cream): apply to mucous membranes or as directed using gloves. Store at room temperature; protect from light.
If a dose is missed
This product is given as a single dose or as part of a defined protocol. Contact your veterinarian if a scheduled administration was missed. Contact your veterinarian for guidance on reproductive timing.
Side Effects
Pyometra/endometrial hyperplasia (intact females). Myelosuppression (estradiol component — monitor CBC). Masculinization of female fetuses. Behavioral changes. Weight gain. Mammary abnormalities. Human skin contact hazard (especially pregnant women).
Precautions
For animals
Intact females: risk of pyometra and endometrial hyperplasia. Stallion-exposed mares: behavioral effects. Monitor for signs of adverse reactions. Not approved for use in food-producing animals. (most formulations).
For people handling this medication
Wear gloves when handling. Combination sex hormones — wear gloves at all times. Keep out of reach of children. Pregnant women and women of childbearing age should avoid contact. Both hormones can be absorbed dermally and cause hormonal effects. Women of childbearing age should use extra precautions.
Overdose
Contact your veterinarian. Progesterone overdose causes prolonged progestogenic effects and may affect reproductive outcomes.
Progesterone/estradiol dosage forms
| Product | Strength | Form | Size | Type |
|---|---|---|---|---|
| PROGESTERONE/ESTRADIOL 150 MG/5 MG PER ML INJECTABLE (LONG ACTING) - 10 ML | 150 MG/5 MG PER ML | Injectable | 10 ML | Compound |
| PROGESTERONE/ESTRADIOL 50 MG/3.33 MG PER ML INJECTABLE (DAILY) - 30 ML | 50 MG/3.33 MG PER ML | Injectable | 30 ML | Compound |
Sources
This information is provided for educational purposes and is not a substitute for advice from your veterinarian. Source: Merck Veterinary Manual – Systemic Pharmacotherapeutics of the Reproductive System (https://www.merckvetmanual.com/pharmacology/systemic-pharmacotherapeutics-of-the-reproductive-system/overview-of-systemic-pharmacotherapeutics-of-the-reproductive-system-in-animals); Plumb's Veterinary Drug Handbook (Plumb, D.C., app.plumbs.com)